A 26-year-old woman (G2P1A1) presented with a 5-week history of multiple red marks on her body after a therapeutic abortion. A physical examination found 15 palpable red marks on her head, neck, chest, arms and legs. Proliferating endothelial cells, which expressed CD31, CD34, von Willebrand factor, but not Glut-1 and merosin, were observed in the lesional area by histopathological analyses. Histocompatibility antigen typing of 2 lesions was identical to a sample from peripheral blood. Accelerated regression was observed in 2 lesions treated by intralesional injection of betamethasone, while spontaneous regression was observed within 9 months in the remaining lesions without any treatment. Rapid growth, spontaneous regression and histological analyses in this case support the diagnosis of ‘infantile hemangioma-like vascular lesion'.

1.
Jacobs AH, Walton RG: The incidence of birthmarks in the neonate. Pediatrics 1976;58:218-222.
2.
Amir J, Metzker A, Krikler R, Reisner SH: Strawberry hemangioma in preterm infants. Pediatr Dermatol 1986;3:331-332.
3.
Mulliken JB, Glowacki J: Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics. Plast Reconstruct Surg 1982;69:412-422.
4.
Dethlefsen SM, Mulliken JB, Glowacki J: An ultrastructural study of mast cell interactions in hemangiomas. Ultrastruct Pathol 1986;10:175-183.
5.
Mulliken JB, Young A (ed): Vascular Birthmarks: Haemangiomas and Vascular Malformations. Philadelphia, Saunders, 1988, p 41.
6.
Chang EI, Thangarajah H, Hamou C, Gurtner GC: Hypoxia, hormones, and endothelial progenitor cells in hemangioma. Lymphatic Res Biol 2007;5:237-243.
7.
Sasaki GH, Pang CY, Wittliff JL: Pathogenesis and treatment of infant skin strawberry hemangiomas: clinical and in vitro studies of hormonal effects. Plast Reconstruct Surg 1984;73:359-370.
8.
Boye E, Yu Y, Paranya G, Mulliken JB, Olsen BR, Bischoff J: Clonality and altered behavior of endothelial cells from hemangiomas. J Clin Invest 2001;107:745-752.
9.
Walter JW, North PE, Waner M, Mizeracki A, Blei F, Walker JW, Reinisch JF, Marchuk DA: Somatic mutation of vascular endothelial growth factor receptors in juvenile hemangioma. Genes Chromosomes Cancer 2002;33:295-303.
10.
Lo K, Mihm M, Fay A: Current theories on the pathogenesis of infantile hemangioma. Semin Ophthalmol 2009;24:172-177.
11.
Barnes CM, Christison-Lagay EA, Folkman J: The placenta theory and the origin of infantile hemangioma. Lymphatic Res Biol 2007;5:245-255.
12.
Bauland CG, Smit JM, Bartelink LR, Zondervan HA, Spauwen PH: Hemangioma in the newborn: increased incidence after chorionic villus sampling. Prenatal Diagn 2010;30:913-917.
13.
North PE, Waner M, Mizeracki A, Mrak RE, Nicholas R, Kincannon J, Suen JY, Mihm MC Jr: A unique microvascular phenotype shared by juvenile hemangiomas and human placenta. Arch Dermatol 2001;137:559-570.
14.
Kroumpouzos G, Cohen LM: Dermatoses of pregnancy. J Am Acad Dermatol 2001;45:1-19, quiz 19-22.
15.
Martin AG, Leal-Khouri S: Physiologic skin changes associated with pregnancy. Int J Dermatol 1992;31:375-378.
16.
Freitas TM, Miguel MC, Silveira EJ, Freitas RA, Galvao HC: Assessment of angiogenic markers in oral hemangiomas and pyogenic granulomas. Exp Mol Pathol 2005;79:79-85.
17.
Johann AC, Salla JT, Gomez RS, de Aguiar MC, Gontijo B, Mesquita RA: Glut-1 in oral benign vascular lesions. Oral Dis 2007;13:51-55.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.